Combined Loss of Hey1 and HeyL Causes Congenital Heart Defects Because of Impaired Epithelial to Mesenchymal Transition

Congenital heart defects affect almost 1% of human newborns. Recently, mutations in Notch ligands and receptors have been found to cause a variety of heart defects in rodents and humans. However, the molecular effects downstream of Notch are still poorly understood. Here we report that combined inactivation of Hey1 and HeyL, two primary target genes of Notch, causes severe heart malformations, including membranous ventricular septal defects and dysplastic atrioventricular and pulmonary valves. These defects lead to congestive cardiac failure with high lethality. We found both genes to be coexpressed with Notch1, Notch2 and the Notch ligand Jagged1 in the endocardium of the atrioventricular canal, representing the primary source of mesenchymal cells forming membraneous septum and valves. Atrioventricular explants from Hey1/HeyL deficient mice exhibited impaired epithelial to mesenchymal transition. Although epithelial to mesenchymal transition was initiated regularly, full transformation into mesenchymal cells failed. This was accompanied by reduced levels of matrix metalloproteinase-2 expression and reduced cell density in endocardial cushions in vivo. We further show that loss of Hey2 leads to very similar deficiencies, whereas a Notch1 null mutation completely abolishes epithelial to mesenchymal transition. Thus, the Hey gene family shows overlap in controlling Notch induced endocardial epithelial to mesenchymal transition, a process critical for valve and septum formation.

[1]  Raymond B. Runyan,et al.  Invasion of mesenchyme into three-dimensional collagen gels: a regional and temporal analysis of interaction in embryonic heart tissue. , 1983, Developmental biology.

[2]  D. L. Weeks,et al.  Epithelial-mesenchymal transformation of embryonic cardiac endothelial cells is inhibited by a modified antisense oligodeoxynucleotide to transforming growth factor beta 3. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[3]  G. Weinmaster,et al.  Notch1 is essential for postimplantation development in mice. , 1994, Genes & development.

[4]  T. Mak,et al.  Disruption of the mouse RBP-J kappa gene results in early embryonic death. , 1995, Development.

[5]  R R Markwald,et al.  Molecular regulation of atrioventricular valvuloseptal morphogenesis. , 1995, Circulation research.

[6]  Paul S. Meltzer,et al.  Mutations in the human Jagged1 gene are responsible for Alagille syndrome , 1997, Nature Genetics.

[7]  Colin C. Collins,et al.  Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1 , 1997, Nature Genetics.

[8]  M. Gessler,et al.  Developmental expression patterns of mouse sFRP genes encoding members of the secreted frizzled related protein family , 1998, Mechanisms of Development.

[9]  S. Artavanis-Tsakonas,et al.  Notch signaling: cell fate control and signal integration in development. , 1999, Science.

[10]  Manfred Gessler,et al.  Hey genes: a novel subfamily of hairy- and Enhancer of split related genes specifically expressed during mouse embryogenesis , 1999, Mechanisms of Development.

[11]  H. Macdonald,et al.  Deficient T cell fate specification in mice with an induced inactivation of Notch1. , 1999, Immunity.

[12]  Wanmin Song,et al.  Degradation of type IV collagen by matrix metalloproteinases is an important step in the epithelial-mesenchymal transformation of the endocardial cushions. , 2000, Developmental biology.

[13]  M. Gessler,et al.  Activation of the Notch pathway in the hair cortex leads to aberrant differentiation of the adjacent hair-shaft layers. , 2000, Development.

[14]  D. Srivastava,et al.  Members of the HRT family of basic helix-loop-helix proteins act as transcriptional repressors downstream of Notch signaling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Gessler,et al.  Comparative analysis of the human and mouse Hey1 promoter: Hey genes are new Notch target genes. , 2000, Biochemical and biophysical research communications.

[16]  C. Steidl,et al.  Characterization of the human and mouse HEY1, HEY2, and HEYL genes: cloning, mapping, and mutation screening of a new bHLH gene family. , 2000, Genomics.

[17]  C. Steidl,et al.  Analysis of HeyL expression in wild-type and Notch pathway mutant mouse embryos , 2000, Mechanisms of Development.

[18]  A. Hamosh,et al.  Familial Tetralogy of Fallot caused by mutation in the jagged1 gene. , 2001, Human molecular genetics.

[19]  Y. Bessho,et al.  Dynamic expression and essential functions of Hes7 in somite segmentation. , 2001, Genes & development.

[20]  L. Kedes,et al.  HERP, a Novel Heterodimer Partner of HES/E(spl) in Notch Signaling , 2001, Molecular and Cellular Biology.

[21]  J. Hoffman,et al.  The incidence of congenital heart disease. , 2002, Journal of the American College of Cardiology.

[22]  S. Klewer,et al.  Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2–ErbB3 receptors , 2002, Nature Medicine.

[23]  Y. Jan,et al.  Tetralogy of Fallot and Other Congenital Heart Defects in Hey2 Mutant Mice , 2002, Current Biology.

[24]  R. Bronson,et al.  Ventricular septal defect and cardiomyopathy in mice lacking the transcription factor CHF1/Hey2 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Fischer,et al.  Mouse gridlock No Aortic Coarctation or Deficiency, but Fatal Cardiac Defects in Hey2 −/− Mice , 2002, Current Biology.

[26]  Peter Friedl,et al.  Compensation mechanism in tumor cell migration , 2003, The Journal of cell biology.

[27]  M. Gessler,et al.  Expression of Notch pathway genes in the embryonic mouse metanephros suggests a role in proximal tubule development. , 2003, Gene expression patterns : GEP.

[28]  T. Camenisch,et al.  Elevated glucose inhibits VEGF-A–mediated endocardial cushion formation , 2003, The Journal of cell biology.

[29]  T. Gridley.  Notch signaling and inherited disease syndromes. , 2003, Human molecular genetics.

[30]  C. Guidos,et al.  Notch signaling in development and disease , 2003, Clinical genetics.

[31]  S. Neubauer,et al.  Rapid identification and 3D reconstruction of complex cardiac malformations in transgenic mouse embryos using fast gradient echo sequence magnetic resonance imaging. , 2003, Journal of molecular and cellular cardiology.

[32]  H. Hosokawa,et al.  Increased invasion and matrix metalloproteinase-2 expression by Snail-induced mesenchymal transition in squamous cell carcinomas. , 2003, International journal of oncology.

[33]  A. Fischer,et al.  Hey genes in cardiovascular development. , 2003, Trends in cardiovascular medicine.

[34]  Randy L. Johnson,et al.  Targeted Disruption of hesr2 Results in Atrioventricular Valve Anomalies That Lead to Heart Dysfunction , 2004, Circulation research.

[35]  P. Friedl.  Prespecification and plasticity: shifting mechanisms of cell migration. , 2004, Current opinion in cell biology.

[36]  A. Fischer,et al.  Phenotypic variability in Hey2 −/− mice and absence of HEY2 mutations in patients with congenital heart defects or Alagille syndrome , 2004, Mammalian Genome.

[37]  Frank McCormick,et al.  Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. , 2004, Genes & development.

[38]  Linheng Li,et al.  Notch Activation Results in Phenotypic and Functional Changes Consistent With Endothelial-to-Mesenchymal Transformation , 2004, Circulation research.

[39]  Manfred Gessler,et al.  The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. , 2004, Genes & development.

[40]  D. Srivastava,et al.  Mutations in NOTCH1 cause aortic valve disease , 2005, Nature.

[41]  S. Elledge,et al.  A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[42]  G. Wahl,et al.  Reproducible doxycycline-inducible transgene expression at specific loci generated by Cre-recombinase mediated cassette exchange , 2005, Nucleic acids research.

[43]  A. Fischer,et al.  Hey Basic Helix-Loop-Helix Transcription Factors Are Repressors of GATA4 and GATA6 and Restrict Expression of the GATA Target Gene ANF in Fetal Hearts , 2005, Molecular and Cellular Biology.

[44]  Zhiwei Wang,et al.  Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. , 2006, Cancer research.